CiVi Biopharma ApS: Financial statements 2021
CVR: 38027794
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CiVi Biopharma ApS (CVR 38027794) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 4,035,566 and a net result of DKK 344,004 compared with DKK 391,972 the year before. That is a decrease of 10% compared with the year before. Equity in the 2021 report amounted to DKK 3,049,035. The solvency ratio was 70.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 4,035,566
- Profit/Loss
- DKK 344,004
- Equity
- DKK 3,049,035
- Total Assets
- DKK 4,332,148
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 4M | 344K | 3M | 1 |
| 2020 | - | 4.5M | 392K | 2.7M | 1 |
| 2019 | - | 7.2M | 649K | 2.3M | 1 |
| 2018 | - | 6M | 707K | 1.7M | 1 |
Official annual report
Find more companies like CiVi Biopharma ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
CiVi Biopharma ApS has published its annual report for 2020. Gross profit came to DKK 4,484,621, and the net result was DKK 391,972.
About CiVi Biopharma ApS
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 5 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.